Showing 501 - 520 results of 39,775 for search '(( 50 ((ppm decrease) OR (nn decrease)) ) OR ( 5 ((ng decrease) OR (we decrease)) ))', query time: 0.69s Refine Results
  1. 501
  2. 502

    Effect of 10 ng of IL-1β and IL-1Ra in a preliminary recording of the LFPs in the OB. by Adriana Jiménez (3551204)

    Published 2025
    “…<p>A) A single dose of 10 ng of IL-1β decreased the amplitude of LFPs in the OB immediately after its microinjection, reaching a maximum effect at approximately 10 min and remaining constant for at least 45 min. …”
  3. 503
  4. 504
  5. 505
  6. 506
  7. 507
  8. 508

    Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

    Published 2013
    “…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75<sup>NTR</sup>-siRNA and p75<sup>NTR</sup>/trkA<sup>NGFR</sup>-siRNA (p<.05).…”
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513
  14. 514
  15. 515
  16. 516

    TNFα decreased Best-3 expression in endothelium. by Wei Song (30780)

    Published 2014
    “…(<b>C, D</b>) HUVECs were stimulated with TNFα (10 ng/ml) for different times as indicated. Quantitative PCR (C) and western blot (D) results show a time-dependent decrease of Best-3 expression. …”
  17. 517
  18. 518
  19. 519

    Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  20. 520

    Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”